Planning for Implementation of Decentralized Clinical Trials in APAC: A Global Overview

Life Sciences, Clinical Trials, Pharmaceutical Regulation, Drug Discovery & Development, Emerging Market,
  • Tuesday, October 19, 2021

Focus on decentralized clinical trials (DCTs) has taken a massive leap over the course of the pandemic. COVID-19 forced an accelerated use of telemedicine, home health options and digital applications to keep studies running. Emerging from COVID-19, the use of decentralized solutions continues to rise worldwide. Although somewhat slower to adopt, the Asia-Pacific (APAC) region has seen a dramatic shift in elements critical to implementation of decentralized solutions, including emerging clarity in regulatory guidance and greater acceptance of home health services, which will serve as important drivers of accelerated future use of decentralized clinical trials.

As APAC developers continue to explore opportunities to incorporate decentralized clinical trials into their clinical strategies, understanding what is working well in other markets – whether it be with the intent of leveraging to bring their asset into those markets or with an eye toward adapting these best practices to the unique APAC landscape – is key to success.

Register for this webinar to learn best practices for decentralized clinical trials implementation and how these can be applied to APAC trials.


Russell Griffith, Decentralized Clinical Trials Manager, Syneos Health

Russell has more than 12 years of experience in the CRO environment.  As a global project manager he has managed large, global, phase II/III studies in a variety of areas, primarily focused on rare disease respiratory studies.  As a project manager he implemented decentralized solutions and saw the need for the industry to continue to grow in decentralized offerings to best meet patient and client needs.  Russell now serves as a DCT Manager working to guide the project team within Syneos Health to help studies effectively apply decentralized solutions that decrease the patient and site burden and enhance clinical trial outcomes.

Before joining the Syneos Health decentralized solutions team, Russell worked at IQVIA and PAREXEL in clinical and project management roles. He received his BBA from James Madison University.

Message Presenter

Kevin Wightman, Senior Director, Corporate and Business Development, Illingworth Research Group

With more than 25 years’ experience in leading pharma, CRO, site and patient-centric solutions providers across Asia-Pacific, the US and Europe, Kevin is passionate about improving the way clinical trials are delivered to better meet patients’ needs. With industry association and not-for-profit Board Director experience, Kevin brings unique perspectives, stakeholder networks and insights from both industry and site angles. In his role as Senior Director of Corporate and Business Development, leading Illingworth Research Group’s expansion in the Asia-Pacific region, Kevin continues to follow his passion as a “patient pioneer,” making clinical trials more accessible and less burdensome for patients and their families and carers. Kevin originally graduated in Pharmacology from Nottingham University in the UK and has worked in Australia for over 20 years.

Message Presenter

Francesca Scaramozzino, Senior Project Director, Real World Late Phase, Syneos Health

Bio coming soon…

Message Presenter

Who Should Attend?

This webinar will be of interest to APAC-based biopharmaceutical professionals engaged in clinical operations functions

What You Will Learn

In this webinar, attendees will:

  • Learn implementation tactics and benefits of decentralized clinical trials in the US and Europe
  • Review case studies illustrating best practices for decentralized clinical trials implementation – and how these can be applied to APAC trials
  • Understand critical regulatory, site-specific and cultural implications to consider when applying the principles of decentralized clinical trials in APAC

Xtalks Partner

Syneos Health

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 26,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit or subscribe to our podcast.

Media Partner

The original site for employees in the pharma, medical, diagnostic and related industries. Our hand-curated daily news feed and active message forums will keep you informed.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account